MUSE Microscopy, Inc. Welcomes Dr. Derek C. Welch to Board of Directors, Appoints Him Chair of Science & Technology Committee

  • June 5, 2025
  • Home
  • USA
  • MUSE Microscopy, Inc. Welcomes Dr. Derek C. Welch to Board of Directors, Appoints Him Chair of Science & Technology Committee

IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) — MUSE Microscopy, Inc., a pioneer in digital pathology innovation, proudly announces the appointment of Dr. Derek C. Welch, MD, FCAP, to its Board of Directors. Dr. Welch, the President and Chief Medical Officer of PathGroup, brings over two decades of leadership in pathology and laboratory medicine. He will also serve as Chair of the Science & Technology Committee, collaborating closely with CEO Matthew Nuñez to advance SmartPath MUSE Technology™ (SmartPath)* platform.

Dr. Welch is a board-certified pathologist with extensive experience in anatomic and clinical pathology. He earned his medical degree from Vanderbilt University School of Medicine and completed his residency at Vanderbilt University Medical Center. Since joining PathGroup in 2005, Dr. Welch has been instrumental in expanding one of the nation’s largest integrated pathology networks, overseeing diagnostic services across multiple states.

MUSE Microscopy is at the forefront of transforming pathology through its innovative slide-free digital imaging technology,” said Dr. Welch. “The SmartPath platform has the potential to revolutionize diagnostic workflows, and I am excited to contribute to its development and application across various clinical settings.”

MUSE’s SmartPath technology utilizes Microscopy with Ultraviolet Surface Excitation (MUSE) to generate high-resolution, H&E-like digital images directly from fresh or formalin-fixed tissue samples, eliminating the need for traditional slide preparation. This approach not only accelerates diagnostic processes but also preserves tissue integrity for downstream molecular testing.

“Dr. Welch’s extensive expertise in pathology and his leadership at PathGroup make him an invaluable addition to our board,” said Matthew Nuñez, CEO of MUSE Microscopy. “His insights will be crucial as we continue to develop and deploy our SmartPath platform to enhance diagnostic accuracy and efficiency.”

About MUSE Microscopy, Inc.

MUSE Microscopy is a company that specializes in the application of Microscopy with Ultraviolet Surface Excitation (MUSE). We have developed a MUSE-enabled imaging system for diagnostic assistance in pathology, cytology, and research applications. Our commercial product, SmartPath MUSE Technology™ (SmartPath)*, is a slide-free direct-to-digital imaging platform that aims to transform the patient’s experience and provide healthcare professionals with quick diagnostic information through digital imaging.

To learn more, you can visit their website at https://musemicroscopy.com/ or find them on social media platforms such as Twitter, Facebook, and LinkedIn. *Pending FDA approval.

About PathGroup

PathGroup is one of the largest private providers of comprehensive pathology services in the U.S., with a reputation for delivering fast, accurate, and reliable results across clinical and molecular diagnostics. PathGroup supports physicians, hospitals, and health systems with advanced diagnostic capabilities nationwide.

Limits on Accuracy
This press release is intended to provide information about MUSE Microscopy, Inc.’s research and potential product. Information is believed to be accurate at the time it is created. However, like any printed material, information may become outdated over time. Information may contain technical inaccuracies or typographical errors. Information may be changed or updated without notice. There may also be improvements or changes in the products and services described in this press release at any time without notice. It is important that you rely on the advice of an appropriate professional. Nothing contained in any presentation is to be construed as medical, legal, investment, financial, or other advice. This information is not intended to be a substitute for such advice. MUSE Microscopy, Inc., does not endorse any specific techniques or methods of treatment. Individuals are advised to consult their health care professionals for full information about the potential adverse reactions from use of the medical technologies discussed in this press release. We will use reasonable efforts to include accurate and up-to-date information on the website, but MUSE Microscopy, Inc. makes no warranties or representations as to its accuracy.

Forward-Looking Statements 
Forward-looking statements in this press release are based on our future expectations, plans, prospects, and assumptions regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. The words “termed,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. 

Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law. 

MEDIA CONTACT:
Matthew Nuñez
Tel: 949.813.6121 
[email protected] 

Source: MUSE Microscopy, Inc. 

Join the Evolution. Embrace the Future.

#DigitalPathology #SlideFreeRevolution #SmartPathMUSE

For more information about MUSE Microscopy and its innovative technologies, please visit www.musemicroscopy.com.


Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow